In the current economic climate, especially in the pharmaceutical industry where pipelines have been shrinking and products are taking more time and investment to commercialize, a convincing business case must be made for developing devices. Whilst the inhaler is a complex device with small changes requiring significant investments, patient preferences have come to the fore in the design and development of improved devices today.